Noveko has raised an amount of $17,460,200 pursuant to the exercise of the warrants issued on May 31, 2007

    EKO / TSX Venture Exchange

    MONTREAL, July 3 /CNW Telbec/ - Noveko International Inc. (the
"Corporation") is pleased to announce that it received confirmation that at
least a number of 5,212,000 warrants have been exercised out of the
5,244,000 warrants issued on May 31, 2007 and which could be exercised until
June 30, 2008, at an exercise price of $3.35 per share. The Corporation has so
raised a total amount of $17,460,200, of which an amount of $14,343,025 was
raised after the end of the 9-month period ended March 31, 2008. It is
possible that some of the remaining 32,000 warrants are still in process. The
total number of issued and outstanding shares is now equal to 63,087,727
Class A Shares.
    The funds so raised will be added to the working capital of the
Corporation and will be used to the commercialization of its products, mainly
those connected with its biomedical and environmental activities, and to its
proposed acquisitions.


    Noveko International Inc. is a public holding company. Currently, its
operating subsidiaries are S.A.S. ECM, Noveko Inc., Laboratoire SyMa Inc.,
Bolduc Leroux Inc. and Magnum Pharmaceutics Inc. ECM specializes in portable
real-time ultrasound scanners for veterinary and human medicine. Noveko Inc.
develops biomedical and environmental products derived from its patented
antimicrobial filtration technology (Noveko(TM)) antimicrobial face masks and
air filters). SyMa specializes in sanitizers, sold under the Azuro(TM) brand.
Magnum acts as a manufacturer sales agent for the Noveko Group's biomedical
and environmental products and sanitizers and for other manufacturers. BLI is
involved in the custom processing and distribution of steel products based on
client specifications.

    The information set forth in this press release includes certain
forward-looking statements. Such statements are based on assumptions exposed
to major risks and uncertainties. Although Noveko deems the expectations
reflected in these forward-looking statements to be reasonable, the Company
cannot provide any guarantee as to the materialization of the expectations
reflected in these forward-looking statements. The TSX Venture Exchange has
not reviewed and does not accept responsibility for the adequacy or accuracy
of this release.

For further information:

For further information: André Leroux, Chairman of the Board and Chief
Executive Officer; Alain Bolduc, President and Chief Operating Officer, Noveko
International Inc., (514) 344-3030;

Organization Profile

Noveko International Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890